Skip to main content
SpringerLink
Log in

Lipid metabolism in young males with hypotestosteronaemia and oligospermia prior to, during, and after treatment

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Relationships between plasma testosterone levels and selected parameters of lipid metabolism were studied in a group of young sterile males prior to, during, and after hormone therapy. Initial hypertriacylglycerolaemia and decreased concentrations of HDL cholesterol returned to normal values after 30 days of methyltestosterone administration. LDL cholesterol concentrations decreased significantly as did plasma apolipoprotein B levels. These changes persisted also one month after cessation of treatment. The results suggest that restoration of initially decreased testosterone levels in the studied group of sterile males is associated with the restoration of the lipid profile.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

apo-B:

apolipoprotein B

HDL:

high density lipoproteins

HDL-Ch:

high density lipoprotein cholesterol

LDL:

low density lipoproteins

LDL-Ch:

low density lipoprotein cholesterol

VLDL:

very low density lipoprotein

References

  1. Assmann, G., Schriewer, H., Schulze, H., Oberwittler, W.: Der Stellenwert des HDL-Cholesterol als Risikofaktor der Koronaren-Gefässkrankheit.Internist, 21, 202 (1980).

    PubMed  CAS  Google Scholar 

  2. Bremner, W. J., Vitielko, M. V., Prinz, P. N.: Loss of circadian rhythmicity in blood testosterone levels with aging in normal men.J. Clin. Endocrinol. Metab., 56, 1278 (1983).

    PubMed  CAS  Google Scholar 

  3. Brown, M. S., Goldstein, J. L.: How LDL receptors influence cholesterol and atherosclerosis.Sci. Amer., 251, 58 (1983).

    Article  Google Scholar 

  4. Brown, M. S., Goldstein, J. L.: Lipoprotein receptors in the liver.J. Clin. Invest., 72, 743 (1983).

    Article  PubMed  CAS  Google Scholar 

  5. Carlson, L. A.: Determination of serum triglycerides.J. Atheroscler. Res., 2, 33 (1963).

    Google Scholar 

  6. Cute, C. G., Baron, J. A., Plymate, S. R., Kiel, D. P., Pavia, A. T., Lozner, E. C.: Sex hormones and coronary artery disease.Am. J. Med., 83, 853 (1987).

    Article  Google Scholar 

  7. Curry, M. D., Gustafson, A., Alaupovic, P., McConathy, W. J.: Electroimmunoassay, radial evaluated for quantification of human apolipoprotein-B.Clin. Chem., 24, 280 (1978).

    PubMed  CAS  Google Scholar 

  8. Gidez, L. I., Miller, G. J., Burstein, M., Slage, S., Eder, H. A.: Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure.J. Lipid Res., 23 1206 (1982).

    PubMed  CAS  Google Scholar 

  9. Glueck, C. J., Scheel, D., Fishback, J., Steiner, P.: Progestagens, anabolic-androgenic compounds, estrogens: Effects on triglycerides and postheparin lipolytic enzymes.Lipids, 2, 110 (1972).

    Article  Google Scholar 

  10. Goldberg, R. B., Rabin, D., Alexander, A. N., Doelle, G. C., Getz, G. S.: Suppression of plasma testosterone leads to an increase in serum total and high density lipoprotein cholesterol and apolipoprotein A-I and B.J. Clin. Endocrinol. Metab., 60, 203 (1985).

    PubMed  CAS  Google Scholar 

  11. Gordon, T., Castelli, W. B., Hjortland, M. D., Kannel, W. B., Dawber, T. R.: High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.Amer. J. Med., 62, 707 (1977).

    Article  PubMed  CAS  Google Scholar 

  12. Gutai, J., Laporte, R., Kuller, L., Dai, F. W., Flavo-Gerard, L., Caggiula, A.: Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions.Amer. J. Cardiol., 48, 897 (1987).

    Article  Google Scholar 

  13. Háčik, T., Hromadová, M.: Effect of short-term androgen administration to rabbit females on their lipoprotein metabolism.Endocrinol. Exper. 22, 181 (1988).

    Google Scholar 

  14. Haffner, S. M., Kushwaha, R. S., Foster, D. M., Applebaum-Bowden, D., Hazzard, W. R.: Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy.Metabolism, 32, 413 (1983).

    Article  PubMed  CAS  Google Scholar 

  15. Hazzard, W. R., Kuswaha, R. S., Applebaum-Bowden, D., Haffner, S. M., Steinmetz, A., Foster, D. M.: Chylomicron very low-density lipoprotein apolipoprotein B metabolism: Mechanism of the response to stanozolol in a patient with severe hypertriglyceridemia.Metabolism, 33, 873 (1984).

    Article  PubMed  CAS  Google Scholar 

  16. Heiss, G., Tamir, I., Davis, C. E., Tyroler, H. A., Rifkind, B. M., Schoenefeld, G., Jacobs, D., Frantz, I. D.: Lipoprotein-cholesterol distributions in selected North-American populations: The Lipid Research Clinic Program Prevalence Study.Circulation, 61, 302 (1980).

    PubMed  CAS  Google Scholar 

  17. Hromadová, M., Háčik, T.: Intersex differences in plasma lipid content and in various lipoprotein fractions in New Zealand Albino rabbits.Endocrinol. Exper., 18, 255 (1984).

    Google Scholar 

  18. Hromadová, M., Háčik, T., Riečanský, I.: Concentration of lipid, apolipoprotein-B and testosterone in patients with coronarographic findings.Klin. Wochenschr., 63, 1071 (1985).

    Article  PubMed  Google Scholar 

  19. Hromadová, M., Háčik, T.: Effect of short-term estrogen administration on lipoprotein metabolism of male rabbits.Exper. Clin. Endocrinol., 91, 91 (1988).

    Google Scholar 

  20. Kuusi, T., Saarinen, P., Nikkilä, E. A.: Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein in man.Atheroscler., 36, 589 (1980).

    Article  CAS  Google Scholar 

  21. Laplaud, P. M., Barussias, B., Beaubatie, L., Maurel, D.: A year-long study of changes induced by castration in the plasma lipid and lipoprotein spectrum in the European badger.Atheroscler., 61, 43 (1986).

    Article  CAS  Google Scholar 

  22. Mendoza, S. G., Osuna, A., Zerpa, A., Gartside, P. S., Glueck, C. J.: Hypertriglyceridemia and hypoalfalipoproteinemia in azoospermic and oligospermic young men: relationships of endogenous testosterone to triglyceride and high density lipoprotein cholesterol metabolism.Metabolism, 30, 481 (1981).

    Article  PubMed  CAS  Google Scholar 

  23. Moorjani, S., Dupont, A., Labrie, F., Lupien, P., Gagné, C., Brun, D., Giguere, M., Bélanger, A., Cusan, L.: Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing hormone-releasing hormone agonist and flutamide.J. Clin. Endocrinol. Metab., 66, 314 (1988).

    PubMed  CAS  Google Scholar 

  24. Reuter, W., Herrmann, W.: Klinische Bedeutung des HDL-Cholesterols.Z. Ges. Inn. Med., 36, 473 (1981).

    PubMed  CAS  Google Scholar 

  25. Rudel, L. L., Morris, M. D.: Determination of cholesterol using o-phalaldehyde.J. Lipid. Res., 14, 364 (1973).

    PubMed  CAS  Google Scholar 

  26. Sorva, R., Kuusi, T., Taskinen, M. R., Perheenstupe, J., Nikkilä, E. A.: Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal males.Atherosclerosis, 69, 191 (1988).

    Article  PubMed  CAS  Google Scholar 

  27. Šeböková, E., Kolena, J.: Characterization of specific prostaglandin E1 receptor in isolated rat Leydig cells.Endocrinol. Exper., 12, 147 (1978).

    Google Scholar 

  28. Taggart, H. M., Applebaum-Bowden, D., Haffner, S., Warnick, G. R., Cheung, M. C., Albers, J. J., Chestnut, Ch. H. III, Hazzard, W. R.: Reduction in high density lipoproteins by anabolic steroid (Stanozol) therapy for postmenopausal osteoporosis.Metabolism, 31, 1147 (1982).

    Article  PubMed  CAS  Google Scholar 

  29. Vermeulen, A., Rubens, R., Verdonck, L.: Testosterone secretion and metabolism in male senescence.J. Clin. Endocrinol. Metab., 34, 730 (1972).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Experimental Endocrinology, Centre of Physiological Sciences, Slovak Academy of Sciences, Bratislava, Czechoslovakia

    M. Hromadová & T. Háčik

  2. Clinics of Urology, Bratislava, Czechoslovakia

    E. Malatinský, A. Sklovský, J. Cervenakov & F. Lábady

Authors
  1. M. Hromadová
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Háčik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Malatinský
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Sklovský
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Cervenakov
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Lábady
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hromadová, M., Háčik, T., Malatinský, E. et al. Lipid metabolism in young males with hypotestosteronaemia and oligospermia prior to, during, and after treatment. International Urology and Nephrology 23, 69–75 (1991). https://doi.org/10.1007/BF02549731

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02549731

Keywords

Search

Navigation